Investing $25 million in imaging sciences

Investing $25 million in imaging sciences

Washington University in St. Louis is launching a bold $25 million initiative over the next five years to develop innovative technologies aimed at improving science and medicine worldwide. The Imaging Sciences Initiative – a partnership between the School of Engineering & Applied Science and the School of Medicine – will support the development of new imaging technologies to diagnose and treat disease as well as study intricate biological structures, metabolism and physiology, and critical molecular and cellular processes.
Washington People: Marilyn Siegel

Washington People: Marilyn Siegel

Marilyn Siegel, MD, a professor of radiology and of pediatrics, loves solving the puzzles her field presents and the opportunities it has given her. But most of all, she loves helping patients.

Washington People: Sally Schwarz

The nuclear pharmacist with a flair for design is working to keep Mallinckrodt Institute of Radiology at the forefront of research and patient care.

Siegel receives Cassen Prize

Barry Siegel, MD, professor of radiology at the School of Medicine, was awarded the Benedict Cassen Prize for Research in Nuclear Medicine during the annual meeting of the Society of Nuclear Medicine and Molecular Imaging. The meeting was June 7-11 in St. Louis.

Habif center now offers on-site diagnostic imaging

Through a new partnership between the Habif Health and Wellness Center and the Mallinckrodt Institute of Radiology, students now can have diagnostic X-rays taken right on the South 40. WUSTL has invested in equipment and human resources to make quality medical care even more accessible to nearly 10,000 undergraduate and graduate students.

CT screening reduces lung-cancer deaths in heavy smokers

In a study of heavy smokers, fewer screened with low-dose CT scans died, compared with similar smokers screened with standard chest X-rays. The National Cancer Institute ran the 33-center National Lung Screening Trial to learn whether more sensitive screening could have an impact on lung-cancer deaths, and Washington University researchers involved in the study say it did.